Latest Breaking News On - ஆராய்ச்சி க்கு ப்ரெவெந்ஶந் - Page 2 : vimarsana.com

Potential HIV vaccine utilizing same mRNA technology as COVID-19 vaccine shows promise in early human trial By Chris Williams Antibodies are Y-shaped proteins than bind to one s foreign invaders, like viruses, bacteria, fungi and parasites. NEW YORK - A potential HIV vaccine, looking to mirror mRNA COVID-19 vaccine technology, is showing promising results in phase 1 clinical trial testing, according to developers. Researchers at the International AIDS Vaccine Initiative and Scripps Research said the vaccine had success in producing rare immune cells that trigger antibodies to keep the virus from mutating. The response was shown in 97% of participants who received the vaccine, according to the organizations.

United statesMark feinbergScripps researchUs centers for diseaseScripps research immunologist william schiefResearch for preventionVaccine initiativeResearch immunologist william schiefTripura stateDisease controlஒன்றுபட்டது மாநிலங்களில்குறி ஃபைன்பெர்க்ஸ்கிரிப்ட்கள் ஆராய்ச்சிஎங்களுக்கு மையங்கள் க்கு நோய்ஆராய்ச்சி க்கு ப்ரெவெந்ஶந்தடுப்பூசி முயற்சி